Adjuvant chemotherapy with cisplatin, etoposide, fluorouracil and leucovorin for gastric carcinoma

Journal of B.U.ON.

Volumn 11, Issue 3, 2006, Pages 285-289

  Papadakou, M ^a   Xydakis, E ^a   Bonios, M ^a   Makroupoulou, M ^a   Boukis, C ^a   Kakavoulis, T ^b   Karaliotas, C ^c   Panagos, Gerasimos ^a,d  

^a AGII ANARGIRI CANCER HOSPITAL   (Greece)

^b AGIA OLGA HOSPITAL   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

^d NONE   (Greece)

Author keywords

5 flourouracil; Adjuvant chemotherapy; Cisplatin; Etoposide; Gastric cancer; Leucovorin

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ERYTHROPOIETIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG FATALITY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MALE; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; SEPSIS; STOMACH ADENOCARCINOMA; STOMATITIS; THROMBOCYTOPENIA;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 33751039694     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Hundahl S, Philips J, Menck H et al. The National Cancer Database Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy. Cancer 2000; 88: 921-932.
3. Lim L, Michael M, Mann G, Leong T. Adjuvant therapy in gastric cancer. J Clin Oncol 2005; 23: 6220-6232.
4. Nakajima T, Fukami A, Ohashi I et al. Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C. Int J Clin Pharmacol Biopharm 1978; 16: 209-216.
5. Imanaga H, Nakazato H. Results of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence. World J Surg 1977; 2: 213-221.
6. Nakajima T, Fukami A, Takagi K et al. Adjuvant chemotherapy with mitomycin C, and with a multi-drug combination of mitomycin C, 5-fluorouracil and cytosine arabinoside after curative resection of gastric cancer. Jpn J Clin Oncol 1980; 10: 187-194.
7. Ochiai T, Sato H, Hayashi R et al. Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton: 3-6 year follow up of a randomised clinical trial. Cancer Immunol Immunother 1983; 14: 167-171.
8. Maehara Y, Moraguchi S, Sakaguchi Y et al. Adjuvant chemotherapy enhances long term survival of patients with advanced gastric cancer after curative resection. J Surg Oncol 1990; 45: 169-172.
9. Nakajima T, Takahashi T, Takagi K et al. Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer. J Clin Oncol 1984; 2: 1366-1371.
10. Coombes R, Schein P, Chilvers C et al. A randomised trial comparing adjuvant fluorouracil, doxorubicin and mitomycin with no treatment in operable gastric cancer. J Clin Oncol 1990; 8: 1362-1369.
11. Fujii M, Sakabe T, Wakabayashi K et al. The optimal period for orally administered fluoropyrimidines as an adjuvant chemotherapy for gastric cancer: A pilot study using 5-FU tablets compared with surgical operation alone. Gan To Kagaku Ryoho 1994; 21: 1199-1208.
12. Lise M, Nitti D, Marchet A et al. Prognostic factors in resectable gastric cancer: Results of EORTC study no. 40813 on FAM adjuvant chemotherapy. Ann Surg Oncol 1995; 2: 495-501.
13. McDonald JS, Fleming TR, Petercon R et al. Adjuvant chemotherapy with 5FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study. Ann Surg Oncol 1995; 2:488-494.
14. Nakajima T, Nashimoto A, Kitamura M et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: A randomised trial. Lancet 1999; 354: 273-277.
15. Bajetta E, Buzzoni R, Mariani L et al. Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Ann Oncol 2002; 13: 299-307.
16. Nashimoto A, Nakajima T, Furukawa H et al. Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol 2009; 21: 2282-2287.
17. Karpeh M, Kelsen D, Tepper J. Cancer of the stomach. In: DeVita VT, Hellman S, Rosenberg S (eds): Cancer: Principles and Practice of Oncology. Philadelphia, Lippincott Williams and Witkins, 2001, pp 1092-1126.
18. Mabel JA, Little AD. Therapeutic synergism in murine tumors for combinations of cisdichlorodiammine platinum with VP-16 or BCNU. Proc Am Assoc Cancer Res Am Soc Clin Oncol 1979; 20: 230.
19. Seeber S, Osieka R, Schmidt CG et al. In vivo resistance towards anthracyclines, etoposide, and cisdiamminedichloroplatinum. Cancer Res 1982; 67:4719-4725.
20. Ajani JA, Mayer RJ, Ota DM, Steele GD, Evans D. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma. J Natl Cancer Inst 1993; 85: 1839-1847.
21. Kang Y, Choi D, Im Y. A phase III randomized comparison of neoadjuvant chemotherapy followed by surgery versus surgery for locally advanced stomach cancer. Proc Am Soc Clin Oncol 1996; 15: 215.
22. Hoff SJ, Stewart JL, Murray MJ et al. Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. Ann Thorac Surg 1993; 56: 282-286.
23. Earle C, Maroun J. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomized trials. Eur J Cancer 1999; 35: 1059-1064.
24. Mari E, Floriani I, Tinazzi A et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials. A study of the GISCAD. Ann Oncol 2000; 11: 837-843.
25. Hermans J, Bonenkamp J, Boon M et al. Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials. J Clin Oncol 1993; 11: 1441-1447.
26. Panzini I, Gianni L, Fattori PP et al. Adjuvant chemotherapy in gastric cancer: A meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 2002; 88: 21-27.
27. McDonald JS, Smalley SR, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-730.
28. Cunningham D, Allum W, Stenning S et al. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). J Clin Oncol 2005; 23: 308s.